Sinovac and Egypt’s GENNVAX Launch sIPV Polio Vaccine Technology Cooperation

This marks a shift from the June agreement's broad local-production framework to a specific product entering implementation, with process alignment, quality management and training as the staged workstreams. The significance lies less in polio itself than in the template: a Chinese vaccine maker exporting technical capability rather than finished doses, with Egypt as the localization site. Whether that model extends beyond sIPV — and how quickly staged milestones translate into actual Egyptian output — is the open question worth tracking.